Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022223 citationsMiwako Kobayashi, Jennifer L. Farrar et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
2023172 citationsMichael Melgar, Amadea Britton et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
2023171 citationsJefferson M. Jones, Katherine E. Fleming-Dutra et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
2023144 citationsKatherine E. Fleming-Dutra, Jefferson M. Jones et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
202467 citationsAmadea Britton, Lauren E. Roper et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
202437 citationsMiwako Kobayashi, Andrew J. Leidner et al.MMWR Morbidity and Mortality Weekly Reportprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Sarah S. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah S. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah S. Long more than expected).
This network shows the impact of papers produced by Sarah S. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah S. Long. The network helps show where Sarah S. Long may publish in the future.
Co-authorship network of co-authors of Sarah S. Long
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah S. Long.
A scholar is included among the top collaborators of Sarah S. Long based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Sarah S. Long. Sarah S. Long is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Kobayashi, Miwako, Andrew J. Leidner, Ryan Gierke, et al.. (2024). Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report. 73(36). 793–798.37 indexed citations breakdown →
3.
Fleming-Dutra, Katherine E., Jefferson M. Jones, Lauren E. Roper, et al.. (2023). Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(41). 1115–1122.144 indexed citations breakdown →
4.
Melgar, Michael, Amadea Britton, Lauren E. Roper, et al.. (2023). Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(29). 793–801.172 indexed citations breakdown →
Jones, Jefferson M., Katherine E. Fleming-Dutra, Mila M. Prill, et al.. (2023). Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(34). 920–925.171 indexed citations breakdown →
7.
Kobayashi, Miwako, Jennifer L. Farrar, Ryan Gierke, et al.. (2022). Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morbidity and Mortality Weekly Report. 71(4). 109–117.223 indexed citations breakdown →
Osthaus, Britta, et al.. (2018). Weathering the weather: effects of the environment on donkey, mule and horse welfare. Create (Canterbury Christ Church University).
Long, Sarah S., et al.. (1992). Epidémiologie des fentes labiales et palatines dans la région Rhône-Alpes/Auvergne/Jura. A propos de 903 cas enregistrés entre 1978 et 1987. 47(2). 133–140.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.